High ERβ expression has been implicated in breast tumour development, and notably in Tamoxifen-resistance60; however, more studies indicate that it may be associated with a more favourable response to treatment73,74, and that its reduction is associated with the transition to a more invasive phenotype60. Here, ESR2 is linked to breast neoplasm.